In a survey of pediatric patients with vitiligo, only 51.4% were offered narrowband ultraviolet B (NB-UVB) phototherapy, and 45.1% received this treatment before the age of 18 years. The main barriers ...
In a phase 2 study, adding narrow-band UVB phototherapy (NB-UVB) resulted in meaningful repigmentation through week 48 without new safety concerns in patients with nonsegmental vitiligo who did not ...
Solius Labs Launches World's First Personalized Sunlight Medical Device A new category of FDA-cleared over-the-counter phototherapy technology: Solius Pro analyzes your skin to deliver an optimal dose ...
Solius Labs, the world’s first Personalized Sunlight company, today announced the launch of Solius Pro, the only FDA-cleared personalized UVB light therapy device available without a prescription.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results